• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Liposomal formulations of photosensitizers.脂质体剂型的光敏剂。
Biomaterials. 2019 Oct;218:119341. doi: 10.1016/j.biomaterials.2019.119341. Epub 2019 Jul 10.
2
Liposomal nanostructures for photosensitizer delivery.用于递送光敏剂的脂质体纳米结构。
Lasers Surg Med. 2011 Sep;43(7):734-48. doi: 10.1002/lsm.21101.
3
Liposomes for photodynamic therapy.用于光动力疗法的脂质体
Adv Drug Deliv Rev. 2004 Jan 13;56(1):17-30. doi: 10.1016/j.addr.2003.07.014.
4
A novel photosensitizer: An l-glutamide lipid conjugate with improved properties for photodynamic therapy.一种新型光敏剂:一种具有改善的光动力疗法性能的L-谷氨酰胺脂质共轭物。
Photochem Photobiol Sci. 2016 Nov 30;15(12):1476-1483. doi: 10.1039/c6pp00304d.
5
Liposomal photosensitizers: potential platforms for anticancer photodynamic therapy.脂质体光敏剂:用于抗癌光动力疗法的潜在平台。
Braz J Med Biol Res. 2011 Aug;44(8):729-37. doi: 10.1590/s0100-879x2011007500091.
6
Liposomes in topical photodynamic therapy.脂质体在局部光动力疗法中的应用。
Expert Opin Drug Deliv. 2012 Aug;9(8):1015-32. doi: 10.1517/17425247.2012.697894. Epub 2012 Jun 25.
7
Photosensitizer delivery for photodynamic therapy of choroidal neovascularization.用于脉络膜新生血管光动力治疗的光敏剂递送
Adv Drug Deliv Rev. 2001 Oct 31;52(1):63-78. doi: 10.1016/s0169-409x(01)00195-8.
8
[Delivery of photosensitizers for photodynamic therapy].[用于光动力疗法的光敏剂递送]
Korean J Gastroenterol. 2007 May;49(5):300-13.
9
Liposome-encapsulated photosensitizers against bacteria.用于抗菌的脂质体包裹光敏剂。
Recent Pat Antiinfect Drug Discov. 2013 Aug;8(2):100-7. doi: 10.2174/1574891x113089990011.
10
Upconversion nanoparticle-based optogenetic nanosystem for photodynamic therapy and cascade gene therapy.用于光动力疗法和级联基因治疗的基于上转换纳米颗粒的光遗传学纳米系统。
Acta Biomater. 2023 Feb;157:538-550. doi: 10.1016/j.actbio.2022.12.002. Epub 2022 Dec 6.

引用本文的文献

1
A catalase-powered self-oxygen-generating soft nanomotor for photodynamic therapy of osteosarcoma.一种用于骨肉瘤光动力治疗的过氧化氢酶驱动的自供氧软纳米马达。
Mater Today Bio. 2025 Apr 23;32:101796. doi: 10.1016/j.mtbio.2025.101796. eCollection 2025 Jun.
2
Insights into Liposomal and Gel-Based Formulations for Dermatological Treatments.皮肤治疗用脂质体和凝胶制剂的见解
Gels. 2025 Mar 26;11(4):245. doi: 10.3390/gels11040245.
3
Applications and enhancement strategies of ROS-based non-invasive therapies in cancer treatment.基于活性氧的非侵入性疗法在癌症治疗中的应用及增强策略。
Redox Biol. 2025 Mar;80:103515. doi: 10.1016/j.redox.2025.103515. Epub 2025 Jan 28.
4
A general strategy towards activatable nanophotosensitizer for phototoxicity-free photodynamic therapy.一种用于无光毒性光动力疗法的可激活纳米光敏剂的通用策略。
Theranostics. 2025 Jan 1;15(3):943-964. doi: 10.7150/thno.100597. eCollection 2025.
5
Light enhanced cytotoxicity and antitumoral effect of a ruthenium-based photosensitizer inspired from natural alkaloids.光增强了一种受天然生物碱启发的钌基光敏剂的细胞毒性和抗肿瘤作用。
RSC Med Chem. 2024 Oct 25;16(2):779-90. doi: 10.1039/d4md00600c.
6
Smart molecular designs and applications of activatable organic photosensitizers.可激活有机光敏剂的智能分子设计与应用
Nat Rev Chem. 2025 Jan;9(1):46-60. doi: 10.1038/s41570-024-00662-7. Epub 2024 Nov 6.
7
Integrating mTOR Inhibition and Photodynamic Therapy Based on Carrier-Free Nanodrugs for Breast Cancer Immunotherapy.基于无载体纳米药物整合mTOR抑制与光动力疗法用于乳腺癌免疫治疗
Adv Healthc Mater. 2024 Dec;13(31):e2402357. doi: 10.1002/adhm.202402357. Epub 2024 Sep 5.
8
Supramolecular dye nanoassemblies for advanced diagnostics and therapies.用于先进诊断和治疗的超分子染料纳米组装体。
Bioeng Transl Med. 2024 Feb 13;9(4):e10652. doi: 10.1002/btm2.10652. eCollection 2024 Jul.
9
A Physiochemical, and Comparative Analysis of Verteporfin-Lipid Conjugate Formulations: Solid Lipid Nanoparticles and Liposomes.脂質偶聯物脂質體和固態脂質奈米粒之物理化學及比較分析:血影蛋白脂質偶聯物。
ACS Appl Bio Mater. 2024 Jul 15;7(7):4427-4441. doi: 10.1021/acsabm.4c00316. Epub 2024 Jun 27.
10
In Vitro Antimicrobial Photodynamic Therapy for () and (MRSA) Inhibition Using a Green Light Source.使用绿色光源的体外抗菌光动力疗法对()和耐甲氧西林金黄色葡萄球菌(MRSA)的抑制作用
Pharmaceutics. 2024 Apr 9;16(4):518. doi: 10.3390/pharmaceutics16040518.

本文引用的文献

1
Multifunctional Hybrid Liposome as a Theranostic Platform for Magnetic Resonance Imaging Guided Photothermal Therapy.多功能混合脂质体作为磁共振成像引导光热治疗的诊疗平台
ACS Biomater Sci Eng. 2018 Jul 9;4(7):2597-2605. doi: 10.1021/acsbiomaterials.8b00176. Epub 2018 Jun 11.
2
Plasmonic liposomes for synergistic photodynamic and photothermal therapy.用于协同光动力和光热治疗的等离子体脂质体。
J Mater Chem B. 2014 May 7;2(17):2592-2597. doi: 10.1039/c3tb21452d. Epub 2014 Feb 18.
3
Dimeric BODIPY-loaded liposomes for dual hypoxia marker imaging and activatable photodynamic therapy against tumors.负载二聚体BODIPY的脂质体用于双缺氧标志物成像及针对肿瘤的可激活光动力疗法
J Mater Chem B. 2018 Jul 14;6(26):4351-4359. doi: 10.1039/c8tb00665b. Epub 2018 Jun 21.
4
Porphyrin-lipid assemblies and nanovesicles overcome ABC transporter-mediated photodynamic therapy resistance in cancer cells.卟啉脂质组装体和纳米囊泡克服 ABC 转运蛋白介导的癌细胞光动力治疗耐药性。
Cancer Lett. 2019 Aug 10;457:110-118. doi: 10.1016/j.canlet.2019.04.037. Epub 2019 May 6.
5
Binding of an amphiphilic phthalocyanine to pre-formed liposomes confers light-triggered cargo release.两亲性酞菁与预先形成的脂质体结合可实现光触发的货物释放。
J Mater Chem B. 2018 Nov 28;6(44):7298-7305. doi: 10.1039/C8TB01602J. Epub 2018 Aug 22.
6
Nanoliposomes Co-Encapsulating CT Imaging Contrast Agent and Photosensitizer for Enhanced, Imaging Guided Photodynamic Therapy of Cancer.载 CT 成像造影剂和光敏剂的纳米脂质体用于增强癌症的成像引导光动力治疗。
Theranostics. 2019 Feb 12;9(5):1323-1335. doi: 10.7150/thno.31079. eCollection 2019.
7
Assembly of upconversion nanophotosensitizer in vivo to achieve scatheless real-time imaging and selective photodynamic therapy.体内上转换纳米敏化剂的组装以实现无创实时成像和选择性光动力治疗。
Biomaterials. 2019 May;201:33-41. doi: 10.1016/j.biomaterials.2019.02.015. Epub 2019 Feb 13.
8
Photodynamic Therapy with Liposomes Encapsulating Photosensitizers with Aggregation-Induced Emission.载光敏剂脂质体的光动力疗法,其光敏剂具有聚集诱导发光。
Nano Lett. 2019 Mar 13;19(3):1821-1826. doi: 10.1021/acs.nanolett.8b04875. Epub 2019 Feb 19.
9
Pharmacokinetics and pharmacodynamics of liposomal chemophototherapy with short drug-light intervals.短药物-光间隔脂质体化学光疗的药代动力学和药效学。
J Control Release. 2019 Mar 10;297:39-47. doi: 10.1016/j.jconrel.2019.01.030. Epub 2019 Jan 23.
10
A Combination of Visudyne and a Lipid-anchored Liposomal Formulation of Benzoporphyrin Derivative Enhances Photodynamic Therapy Efficacy in a 3D Model for Ovarian Cancer.一种维速达尔(Visudyne)与苯并卟啉衍生物脂锚定脂质体配方的联合应用增强了卵巢癌 3D 模型中光动力疗法的疗效。
Photochem Photobiol. 2019 Jan;95(1):419-429. doi: 10.1111/php.13066. Epub 2019 Jan 7.

脂质体剂型的光敏剂。

Liposomal formulations of photosensitizers.

机构信息

Department of Biomedical Engineering, University at Buffalo, State University of New York, Buffalo, NY, 14260, USA.

Department of Biomedical Engineering, University at Buffalo, State University of New York, Buffalo, NY, 14260, USA.

出版信息

Biomaterials. 2019 Oct;218:119341. doi: 10.1016/j.biomaterials.2019.119341. Epub 2019 Jul 10.

DOI:10.1016/j.biomaterials.2019.119341
PMID:31336279
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6663636/
Abstract

Photodynamic therapy (PDT) is a clinical ablation modality to treat cancers and other diseases. PDT involves administration of a photosensitizer, followed by irradiation of target tissue with light. As many photosensitizers are small and hydrophobic, solubilization approaches and nanoscale delivery vehicles have been extensively explored. Liposomes and lipid-based formulations have been used for the past 30 years, and in some cases have been developed into well-defined commercial PDT products. This review provides an overview of common liposomal formulation strategies for photosensitizers for PDT and also photothermal therapy. Furthermore, research efforts have examined the impact of co-loading therapeutic cargo along with photosensitizers within liposomes. Additional recent approaches including imaging, overcoming hypoxia, upconversion and activatable liposomal formulations are discussed.

摘要

光动力疗法(PDT)是一种临床消融方式,用于治疗癌症和其他疾病。PDT 包括施用光敏剂,然后用光照辐射目标组织。由于许多光敏剂体积小且疏水性强,因此广泛探索了增溶方法和纳米级递药载体。过去 30 年来,一直在使用脂质体和基于脂质的制剂,在某些情况下,已将其开发为明确的商业 PDT 产品。本综述概述了用于 PDT 和光热治疗的常见脂质体制剂策略。此外,研究工作还研究了在脂质体中共同负载治疗性 cargo 和光敏剂的影响。还讨论了其他最近的方法,包括成像、克服缺氧、上转换和激活的脂质体制剂。